AGL 38.15 Decreased By ▼ -1.43 (-3.61%)
AIRLINK 125.07 Decreased By ▼ -6.15 (-4.69%)
BOP 6.85 Increased By ▲ 0.04 (0.59%)
CNERGY 4.45 Decreased By ▼ -0.26 (-5.52%)
DCL 7.91 Decreased By ▼ -0.53 (-6.28%)
DFML 37.34 Decreased By ▼ -4.13 (-9.96%)
DGKC 77.77 Decreased By ▼ -4.32 (-5.26%)
FCCL 30.58 Decreased By ▼ -2.52 (-7.61%)
FFBL 68.86 Decreased By ▼ -4.01 (-5.5%)
FFL 11.86 Decreased By ▼ -0.40 (-3.26%)
HUBC 104.50 Decreased By ▼ -6.24 (-5.63%)
HUMNL 13.49 Decreased By ▼ -1.02 (-7.03%)
KEL 4.65 Decreased By ▼ -0.54 (-10.4%)
KOSM 7.17 Decreased By ▼ -0.44 (-5.78%)
MLCF 36.44 Decreased By ▼ -2.46 (-6.32%)
NBP 65.92 Increased By ▲ 1.91 (2.98%)
OGDC 179.53 Decreased By ▼ -13.29 (-6.89%)
PAEL 24.43 Decreased By ▼ -1.25 (-4.87%)
PIBTL 7.15 Decreased By ▼ -0.19 (-2.59%)
PPL 143.70 Decreased By ▼ -10.37 (-6.73%)
PRL 24.32 Decreased By ▼ -1.51 (-5.85%)
PTC 16.40 Decreased By ▼ -1.41 (-7.92%)
SEARL 78.57 Decreased By ▼ -3.73 (-4.53%)
TELE 7.22 Decreased By ▼ -0.54 (-6.96%)
TOMCL 31.97 Decreased By ▼ -1.49 (-4.45%)
TPLP 8.13 Decreased By ▼ -0.36 (-4.24%)
TREET 16.13 Decreased By ▼ -0.49 (-2.95%)
TRG 54.66 Decreased By ▼ -2.74 (-4.77%)
UNITY 27.50 Decreased By ▼ -0.01 (-0.04%)
WTL 1.29 Decreased By ▼ -0.08 (-5.84%)
BR100 10,089 Decreased By -415.2 (-3.95%)
BR30 29,509 Decreased By -1717.6 (-5.5%)
KSE100 94,574 Decreased By -3505.6 (-3.57%)
KSE30 29,445 Decreased By -1113.9 (-3.65%)
Editorials

Gene-editing tech could make people immune to flu, HIV in future

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology
Published February 16, 2019 Updated February 18, 2019

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology, people could soon go immune to flu or even HIV.

Researchers at the Fred Hutchinson Cancer Research Center have developed a new technique for artificially creating advanced and longer-lasting antibodies by gene-editing the DNA of B cells – immune systems white blood cells responsible for creating antibodies.

As per Futurism, several traditional antibody treatments are only effective for a short time period; antibodies tend to break down rapidly, later requiring additional injections. According to scientists, their technique can ultimately allow doctors to overcome this hurdle since the new antibodies would only need to be injected once.

Chinese scientists clone gene-edited monkeys for disease research

The research published in the journal bioRxiv described that initial tests involved 15 mice and showed promising results, providing 82 days of protection against the respiratory syncytial virus (RSV) – a respiratory tract infection that can prove dangerous for children and adults both.

Moreover, according to New Scientist, despite gene-editing being a rapidly growing trend, scientists still need to prove the technique completely safe, which might take few years. But, according to the research, if the technology ever becomes treatment for humans in future, ‘thousands of hospital visits, disabilities, and death could be prevented each year’.

Copyright Business Recorder, 2019

Comments

Comments are closed.